Boosting Breast Cancer Immunotherapy: Microparticulate Approach with Synergistic Adjuvants

Breast cancer is a common malignancy impacting women. A breast cancer vaccine has the potential to provide a non-invasive immunotherapeutic approach to cancer treatment. The proposed research explores the immune pathways activated by a spray-dried microparticulate breast cancer vaccine with dual adjuvants. This presentation provides data from T Cell Quantification and ELISA tests at varying concentrations of POLY:IC and IFA using dendritic cells (DC2.4) and T cells (EL4.IL2). This presentation was originally presented at the 2024 ASHP Midyear Meeting to other pharmacy students and professionals.